Screening for malignant melanoma: A cost-effectiveness analysis

Journal of the American Academy of Dermatology

Volumn 41, Issue 5 I, 1999, Pages 738-745

  Freedberg, K A ^a   Geller, A C ^a   Miller, D R ^a   Lew, R A ^a   Koh, H K ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; COST; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; HIGH RISK POPULATION; HUMAN; LIFE EXPECTANCY; MELANOMA; OUTCOMES RESEARCH; POPULATION MODEL; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST;

EID: 0032723276     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70010-1     Document Type: Article

References (33)

1. DL Miller MA Weinstock Nonmelanoma skin cancer in the United States: incidence J Am Acad Dermatol 30 1994 774 778
2. SH Landis T Murray S Bolden PA Wingo Cancer Statistics, 1998 CA Cancer J Clin 48 1998 6 29
3. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK. SEER Cancer Statistics Review, 1973-1992. PHS, NIH, Bethesda (MD): NIH Publication No. 96-2789.
4. 2nd ed CM Balch AN Houghton GW Milton AJ Sober Seng-Jaw Soong Cutaneous melanoma 1992 JB Lippincott Philadelphia
5. RJ Friedman DS Rigel AW Kopf Early detection of malignant melanoma: the role of physician examination and self-examination of the skin CA Cancer J Clin 35 1985 130 151
6. HK Koh AC Geller DR Miller BE Davis RA Lew Skin cancer: prevention and control Greenwald P, Kramer BS, Weed DL. Cancer prevention and control 1995 Marcel Dekker New York
7. Canadian Task Force on the Periodic Health Examination The periodic health examination: 2, 1984 update Can Med Assoc J 130 1984 1278 1285
8. U.S. Preventive Services Task Force Guide to clinical preventive services 2nd ed 1996 Williams & Wilkins Baltimore
9. International Union Against Cancer Melanoma control manual 1992 UICC Geneva
10. Health Care Financing Administration Bureau of Data Management and Strategy, Medicare Decision Support System, Office of Research 1993
11. DS Rigel Is the ounce of screening and prevention for skin cancer worth the pound of cure? CA Cancer J Clin 48 1998 236 238
12. HK Koh LA Norton AC Geller T Sun DS Rigel DR Miller Evaluation of the American Academy of Dermatology’s national skin cancer early detection and screening program J Am Acad Dermatol 34 1996 971 978
13. HK Koh A Caruso I Gage AC Geller MN Prout H White Evaluation of melanoma/skin cancer screening in Massachusetts Cancer 65 1990 375 379
14. MC Weinstein HV Fineberg Clinical decision analysis 1980 WB Saunders Philadelphia
15. S Karjalainern H Salo L Teppo Basal cell and squamous cell carcinoma of the skin in Finland: site distribution and patient survival Int J Dermatol 28 1989 445 450
16. A Laupacis D Feeny AS Detsky PX Tugwell How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluation Can Med Assoc J 146 1992 473 481
17. JM Eisenberg Clinical economics: a guide to the economic analysis of clinical practice JAMA 262 1989 2879 2886
18. JT Edelson MC Weinstein ANA Tosteson L Williams TH Lee L Goldman Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension JAMA 263 1990 408 413
19. HK Koh AC Geller DR Miller RA Lew Early detection of melanoma: an ounce of prevention may be a ton of work J Am Acad Dermatol 28 1993 645 647
20. HI Hall DR Miller JD Rogers B Bewerse Update on the incidence and mortality from melanoma in the United States J Am Acad Dermatol 40 1999 35 42
21. HK Koh AC Geller DR Miller A Caruso I Gage RA Lew Who is being screened for melanoma/skin cancer? Characteristics of persons screened in Massachusetts J Am Acad Dermatol 24 1991 271 277
22. MA Weinstock Prevalence of the early warning signs of melanoma among participants in the 1989 Rhode Island skin cancer screening J Am Acad Dermatol 23 1990 516 518
23. A Girgis P Clarke RC Burton RW Sanson-Fisher Screening for melanoma by primary health care physicians: a cost-effectiveness analysis J Med Screen 3 1996 47 53
24. M Cristofolini R Bianchi S Bio M Decarli R Micciolo P Cristofilini Analysis of the cost-effectiveness ratio of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy Cancer 71 1993 370 374
25. HK Koh AC Geller DR Miller RA Lew The early detection of and screening for melanoma: international status Cancer 75 1995 674 683
26. DM Parkin Screening for cervix cancer in developing countries AB Miller J Chamberlain NE Day N Hakama PC Prorok Cancer screening. International Union Against Cancer 1991 Cambridge University Press Cambridge, (UK): 184 198
27. L Goldsmith HK Koh B Bewerse B Reilley SW Wyatt W Bergfeld Proceedings from the conference to develop a national skin cancer agenda (executive summary). American Academy of Dermatology and Centers for Disease Control and Prevention. April 8-10, 1995 J Am Acad Dermatol 34 1996 822 823
28. MD Krahn JE Mahoney MH Eckman J Trachtenberg SG Pauker AS Detsky Screening for prostate cancer: a decision analytic view JAMA 272 1994 773 780
29. DM Eddy Screening for cervical cancer Ann Intern Med 113 1990 214 226
30. DM Eddy Screening for breast cancer Ann Intern Med 111 1989 389 399
31. DM Eddy Screening for colorectal cancer Ann Intern Med 113 1990 373 384
32. Standard and Poor Statistical Service. Current statistics, September 1994. Standard and Poor, a Division of McGraw-Hill.
33. United States Bureau of the Census Statistical Abstract of the United States: 1996 116th ed 1996 Washington, DC